Decreasing cardiovascular risk factors in obese individuals using a combination of PGX ® meal replacements and PGX ® granules in a 12-week clinical weight modification program

In this open, clinically based, weight modification program, we determined in six sedentary obese adults (five women; one male; age range 30–62 years) that the combination of a modified calorie diet plus PGX ® meal replacement and PGX ® supplementationresultedinasignificantreductioninseveral cardiovascular risk factors over a 12-week time period. This included a significant improvement in lipids (�0.98 mmol/l LDL-C), reduction in average weight (�9.2 kg), mean reduction in fat (�4.1%) and an increase in fat-free mass (2.8%).